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Aim: Polychemotherapy (PCT), widely used for the antitumor treatment has a pronounced toxic effect on the organism, and its cyto-
static effect sometimes is canceled by multidrug resistance of a neoplasia. Comprehension of the nature and development of patho-
logical changes caused by the PCT during the treatment of cancer is very important to improve the efficiency of the therapy and 
to clarify the mechanisms of tumor-host interactions. This study was aimed to examine PCT impact on kidney cells and tissues in mice 
with transplanted resistant lymphosacroma (RLS) and to analyze morphology of metastases of the tumor in kidney during PCT. Ma-
terials and Methods: Male mice CBA/LacSto (55 animals) were intramuscularly implanted in the right hind paw by 105 cells/ml of tu-
mor RLS (a diffuse large B-cell lymphosarcoma) with multi-drug resistance (MDR) phenotype. Mice received combination of cyclo-
phosphamide (50 mg/kg), oncovin (0.1 mg/kg), hydroxydaunorubicin (4 mg/kg), and prednisone (5 mg/kg) accordingly to CHOP 
scheme each 7 days after inoculation of the tumor. The kidneys were sampled on days 1, 3 and 7 after each series of injection of PCT 
preparations and processed for light and electron microscopy, immunohistochemical analysis of Ki-67 and Apaf-1 proteins also was 
performed. Results: Tumor RLS produced metastases comprised of small cells in the kidneys of mice after 8 days post inoculation. 
Application of PCT resulted in destruction of small-cell metastases and development of many large-cell metastases in kidney. Applica-
tion of PCT induced the development of prominent damage of nephron cells, primarily in S3 segments of proximal tubules. Even one 
series of PCT caused reduction of basal plasma folds in these cells and alteration of mitochondria. Damage of proximal tubules and 
involvement of distal tubules, renal bodies and interstitial tissue in the pathologic process, increased during the experiment. This work 
presents the description of morphological changes in kidney as well as of the tumor metastases under PCT influence. Conclusion: The 
obtained data should be considered while designing of remedies for recovery of internal organs functions after antitumor PCT.
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Polychemotherapy (PCT) is one of the main mo-
dalities for treatment of human tumors, however high 
toxicity limits its application [1, 2]. Kidneys and liver, 
which are responsible for detoxification of the organ-
ism, are most affected by PCT [3, 4], and need special 
treatment to improve their functions. The development 
of pathological changes in these organs during PCT was 
not examined; in publications we can see just recorded 
facts of pathological changes in organs at the moment 
of patient’s death [5, 6]. Meantime, knowledge what 
is the nature of pathological changes caused by PCT 
and how they progress during the courses of PCT is very 
important for understanding of their mechanisms. 
It is necessary to trace the effect of repeated injec-
tions of PCT preparations on the visceral organs in the 
dynamics of disease. Studies of this kind could be per-
formed in appropriate animal experimental models. One 
of such models is diffuse large-B-cell lymphosarcoma 
called “resistant lymphosarcoma” (RLS) in CBA mice. 
The tumor has multi-drug resistance (MDR) phenotype, 
which is due to overexpression of genes mdrlb and bcl-
2, reduced expression of gene p53 and also to low con-
centration of ceramide in tumor cells. These features 
provide “evacuation” of drugs out of the cell and also 
impede initiation of apoptosis in tumor RLS [7, 8]. Such 
type of MDR is observed also in humans [9, 10], what 
makes this experimental model particularly valuable.
Goal of our study was to examine PCT impact 
on kidneys of mice inoculated with tumor RLS and 
to analyze morphology of metastases of the tumor 
in this organ during PCT treatment. We used CHOP 
chemotherapy scheme (cyclophosphamide, hydroxy-
daunorubicin, oncovin, prednisone), which is widely 
used in clinic of lymphomas [2]. We tried to be as close 
as possible to way of human treatment and applied the 
same timing and doses of the preparations at mice 
inoculated with tumor RLS.
MATERIALS AND METHODS
Mice. Male mice of CBA/LacSto line (further CBA) 
weighing 22–25 g were kept under natural lighting 
in cages (10 animals in each) and had free access 
to commercial food and water. Housing and care of the 
animals, as well as the experiments, corresponded 
to article 11 of Helsinki declaration of second Medi-
cal Association (1964), “International guidelines for 
conducting biomedical researches using animals” 
(1985) and “Rules of laboratory practice in Russian 
Federation”(Order of Department of Health № 267, 
19.06.2003).
Tumor. RLS is a diffuse large B-cell lymphosarcoma, 
which was obtained in Institute of Cytology and Genetics 
of SB RAS and maintained in ascities form [11]. The tumor 
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RLS possesses MDR phenotype and is cross-resistant 
to cytostatic preparations such as adriablastin, vinblastin, 
doxorubicin and citarabin [7]. We applied experimental 
protocol of lymphosarcoma modeling in mice devel-
oped earlier [4]. Briefly, tumor cells in ascities fluid were 
washed by saline and diluted with saline to concentration 
105 cells/ml. Mice (55 animals) received 0.2 ml of cell sus-
pension by intramuscular injection in the right hind paw.
Drugs. Cyclophosphamide (Mediafarm, Russia), Hy-
droxydaunorubicin (Mediafarm, Russia), Oncovin (Lens-
Farm, Russia) and Prednisone (Ferain, Russia) were 
dissolved in sterile saline and injected at doses of 50; 4; 
0.1 and 5 mg/kg, respectively. The same concentrations 
are used in humans receiving PCT of lymphosarcomas 
under the scheme CHOP [4].
Experimental model. Mice received standard 
combination of PCT preparations under the scheme 
CHOP each 7 days after inoculation of the tumor: cy-
clophosphamide, oncovin and prednisone were injected 
intraperitoneally at intervals of 20–25 min. The volume 
of each injection was 0.2 or 0.25 ml. The hydroxydauno-
rubicin was injected into tail vein in a volume of 0.1 ml. 
Mice were sacrificed by cervical dislocation, cavities 
were opened and visceral organs visually examined. The 
kidneys were collected from experimental animals after 
1, 3 and 7 days after each injection of PCT preparations. 
Kidneys were cut into two halves along the long axis and 
placed into 4% paraphormaldehyde in Hank’s balanced 
solution for 24–48 h. Five intact mice also were used 
to obtain “normal” kidneys for morphological study.
Histopathological and immunohistochemi-
cal studies. The samples for light microscopy were 
routinely processed using Zeiss STP 120–1 (Zeiss, 
Germany) machine and embedded in paraffin. Sagittal 
sections (3–4 μm) of the whole kidney were prepared 
and routinely stained with hematoxylin and eosin. Par-
affin sections for immunohistochemical analysis were 
mounted on polylysine-coated slides (Thermo Scientific, 
USA). Reactions with antibodies to proteins Ki-67 and 
Apaf-1 were performed according to manufacturer’s pro-
tocols (Abcam, Great Britain). Protein Ki-67 is a nuclear 
protein and serves as a marker of proliferating cells. 
The protein reveals itself in late G1-phase, S-, G2- and 
M-phases of cell cycle and is absent in cells, which are 
in G0-phase. The protein is located in perinuclear region, 
in cell nucleus, and also on chromosomes’ surface [12, 
13]. Protein Apaf-1 (apoptotic peptidase activation fac-
tor 1) is an apoptosis marker and is located in cytosol. 
Apaf-1 is activated by cytochrome-c and takes a part 
in formation of apoptosome and in activation of cas-
pase-9 [14]. Reaction product was visualized by detec-
tion system (Novocastra, Great Britain) and AEC chro-
mogen (Sigma, USA), staining of sections was finished 
with Erlich’s hematoxylin. Immunohistochemical analysis 
of kidneys of mice received the treatment was carried out 
on 1st and 7th days after each injection of the preparations.
Paraffin sections were examined in light micro-
scopes Zeiss Axioscope 40 with digital camera Ax-
ioCam MRc (Zeiss, Germany) and Leica DM 2500 with 
digital camera Leica DFC420 C (Leica, Germany).
Electron microscopy. Fixed kidneys were sliced 
into 1–2 mm thick strips, and postfixed in 1% osmium 
tetroxide solution, routinely processed and embedded 
into a mixture of epon-araldite (SPI, USA). The same 
protocol was applied for processing of tumor RLS 
cells from ascities fluid which was used for the tumor 
incoculation. Semithin sections were prepared from 
hard blocks and stained with Azur 2. The sections were 
examined in light microscope and areas for ultrathin 
sectioning were selected. Ultrathin and semithin sec-
tions were cut on ultramicrotome Ultracut-6 (Reichert-
Young, Austria), routinely contrasted by uranylacetate 
and lead citrate (SPI, USA), and examined in transmis-
sion electron microscope JEM 1400 (Jeol, Japan). The 
images were collected by side-mounted digital camera 
Veleta (SIS, Germany).
RESULTS AND DISCUSSION
RLS tumor cells of ascitic fluid that was used for 
the inoculation of mice have been examined by means 
of electron microscopy. Cell population mainly com-
prised of small cells having diameter of 4–6 μm. 
Remaining cells varied in size and reached 15 μm in di-
ameter. Both small and large cells had roundish shape 
and rare short protrusions on the surface (Fig. 1). Endo-
cytosis vesicles were rare finding. Large nucleus of oval 
or beanlike shape had high content of euchromatin and 
prominent well-structured nucleoli with large granular 
zone. Volume of cytoplasm and number of cell organ-
oids varied in different cells depending on their sizes. 
Cytoplasm had average electron density, grainy struc-
ture and few cisterns of rough endoplasmic reticulum. 
Short oval mitochondria (about 0.5 μm in length) having 
matrix of average electron density and rare cristae were 
accumulated near the nucleus. The Golgi complex was 
small, sparse “coated” and smooth-membrane vesicles 
were seen around short flattened cisterns showing 
low activity of intracellular membrane transport. Mul-
tivesicular bodies and lysosomes were extremely rare 
in tumor RLS cells. Many large cells contained relatively 
big lipid droplets (Fig. 1, b). In general, cells of tumor 
RLS in ascitic fluid showed poor signs of membrane-
associated synthesis and transport against active 
production of ribosomes in large nucleoli. Probably 
the metabolism in ascitic tumor cells mainly occurred 
in non-membrane compartments.
Histological examination of kidneys in mice inocu-
lated with tumor RLS found metastasis foci in pelvis area 
and in cortex (Fig. 2, a, b), while in kidney medulla the 
metastases were not detected during whole experiment. 
The observed distribution of metastases corresponded 
with location of lymphosarcoma metastases in kidneys 
of sick humans [6, 15]. Metastasizing lymphosarcoma 
cells spread mainly by hematogenic way [16], so absence 
of metastases in kidney medulla is probably related to low 
blood flow in this part of the organ.
The kidneys of mice on day 8 after inoculation of the 
tumor RLS showed 6–8 metastases (40–60 μm in size) 
in kidney cortex per sagittal section. Number of me-
tastases in renal pelvis area was 4–6 metastases 
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per section. Sizes of these metastases varied from 
50 to 100 μm after 14 days post inoculation of the 
tumor RLS. All the metastases comprised of identical 
cells having size 4–6 μm. These cells had roundish 
nucleus edged by small ring of weakly basophilic cy-
toplasm (Fig. 2, a, b). The reaction with antibodies for 
Ki-67 protein was negative showing arrest of mitotic 
division of tumor cells. Reaction for Apaf-1 protein also 
was negative, indicating the absence of apoptosis.
The morphology of metastases in kidney cortex and 
in renal pelvis area changed after two series of PCT 
injections (15 days post inoculation of the tumor). In kid-
ney cortex number of metastases consisting of small 
cells decreased, and their size diminished to 20–50 μm. 
Size of metastases in renal pelvis area also decreased 
(to 50–70 μm), number of cell elements lessened, and 
they were separated by layers of connective tissue. 
Metastases located in renal pelvis area contained cells 
positively stained for anti-Apaf-1 protein that indicate 
apoptosis (Fig. 2, c). Reaction with antibodies for Ki-
67 protein was negative in all of the metastases that 
point to suppression of tumor RLS cells proliferation. 
At the same time with regression of small cell metas-
tases we found large tumor cells of 12–18 μm in size 
(some of them exceed 30 μm) in kidney parenchyma. 
On paraffin sections these cells had dark polymorphous 
nucleus with barely discernible borders and huge ho-
mogeneous basophilic cytoplasm (Fig. 2, d).
Next time point of the experiment, 21 days post 
inoculation of the tumor RLS, showed absence of small 
cell metastases in mice kidneys, instead of them large 
cell metastases of 50–80 μm size were observed in kid-
ney cortex. “Explosive” growth of metastases in kidney 
cortex was observed in period of days 22–29 after 
tumor RLS inoculation (3 and 4 series of PCT injec-
tions): their number was 16–22 per sagittal section 
and size was 30–130 μm (Fig. 2, e). The metastases 
in this period consisted only of large cells, which dem-
onstrated proliferative activity (positive reaction with 
anti-Ki-67 antibodies) despite injections of cytostatics. 
No signs of apoptosis were observed.
Electron-microscopic study of large tumor RLS cells 
revealed polymorphous nuclei with matrix of average 
density, small clumps of heterochromatin and promi-
nent large nucleolus (Fig. 2 e, f). The cells contained 
grainy cytoplasm, long cisterns of rough endoplasmic 
reticulum, numerous free ribosomes, well-developed 
cisterns of Golgi complex, multivesicular bodies, elec-
tron dense lipid droplets, “coated” vesicles. Number 
of mitochondria varied from a few to some tens per 
cell section. The structure of large cells in kidney me-
tastases indicated active metabolic processes both 
in membrane- and non-membrane compartments.
Thus, injections of cytostatic preparations under 
the scheme CHOP to mice resulted in disappearance 
of metastases consisting of small (4–5 μm) cells and 
development of metastases formed by large tumor 
cells (12–18 μm). Earlier studies showed that a sus-
pension of cells of ascitic tumor RLS contained 10% 
cells with MDR phenotype [10], thereby we inoculated 
mice with a mixture of 90% sensitive to PCT cells, and 
10% — resistant. We propose that large cells which 
appeared in kidneys during the PCT and formed me-
tastases represent a progeny of MDR phenotype cells 
injected in mice. Apparently PCT serves as selective 
factor for these cells which can proliferate in tumor 
node and then migrate to kidneys. Presence of pro-
liferative activity in large-cell metastases illustrates 
their resistance to PCT. In this way tumor RLS has 
heterogeneous cellular structure and contains at least 
two kinds of cells. Presence of large tumor cells, which 
preserve ability to proliferate and metastasize during 
PCT, supports the concept of “stem” tumor cells, ex-
istence of which was shown in glioblastoma, benign 
papilloma and intestinal adenoma [17–19].
Histological structure of the kidneys in intact CBA 
mice corresponded to those described for this animal 
species [20, 21]. Light microscopy of kidneys on day 8 af-
ter tumor RLS inoculation in mice revealed pathological 
changes which were not directly related with metastases. 
The tissues neighboring with the metastases maintained 
their “normal” histological structure. The injury was 
a b
Fig. 1. Small (a) and large (b) cells of tumor RLS in ascities fluid of CBA mice. 1 — nucleus, 2 — lipid droplet, arrows show the 
nucleoli. Ultrathin sections, transmission electron microscopy (x 40000)
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Fig. 2. Metastases (shown with arrows) of tumor RLS in renal pelvis area (HEx40) (a) and kidney cortex (HEx100) (b) of mice re-
ceived PCT under scheme CHOP, 8 days after tumor inoculation (1 series of PCT injections). Asterisks show kidney tubules. Positive 
reaction with anti-Apaf-1 antibodies (shown by arrows) in pelvis area (x40) (c) of a mouse, 21 days post inoculation of the tumor 
RLS, 2 series of PCT injections. Large tumor cell (shown by arrows) in kidney tissue (HEx100) (d), 15 days post inoculation of the 
tumor, 2 series of PCT injections; asterisk indicates lumen of blood vessel. Metastasis (shown by arrows) in kidney cortex (HEx40) 
(e) 28 days after tumor inoculation, 3 series of PCT injections; asterisks show kidney tubules. Large tumor cells in mice kidney (f, 
g), 28 days after tumor inoculation, 3 series of PCT injections. 1 — nucleus, 2 — nucleolus, arrows show endoplasmic reticulum 
on fig. f, and cell borders — on fig. g. Ultrathin sections, transmission electron microscopy (x 50000, x 15000)
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observed in proximal tubules of outer strip, where S3-
segments of the tubules are located, and involved about 
5% of area in kidney sections. Proximal tubules showed 
widening of lumen and cell debris in the lumens; some 
foci composed of necrotic epitheliocytes and epithelio-
cytes with homogeneous bright eosinofilic cytoplasm 
(2–3 cells in field of view at a 400x magnification) also 
were observed (Fig. 3, a). Eosinophilic cells showed 
high electron density of cytoplasm and hardly discerned 
organoids in ultrathin sections. Similar eosinophilic cells 
in proximal tubules of rodents were described in different 
studies and are considered as a sign of necrotic changes 
of the epitheliocytes [22, 23].
Electron microscopy found decrease of cytoplasm 
density in proximal tubule cells in area of outer strip af-
ter a day post first injections of PCT preparations; many 
of the cells showed visible reduction of folds in basal 
plasmalemma, while number of apical microvilli visually 
did not change (Fig. 3, b). Alteration of plasmalemma 
organization indicates the impairment of ion transport 
and perhaps is related with overlapping impacts of tumor 
process and cytostatic preparations, particularly cyclo-
phosphamide. Cyclophosphamide and its metabolites 
cause dose-dependent rise of expression of aquaporines 
1 and 7 (AQP1 and AQP7) in kidney tubules of rodents 
and thereby disturb water-ion transport. It is interesting 
that expression of AQP7 reveals itself only in cells of S3-
segment of proximal tubules [24, 25]. Another factor 
of alteration of the cells of S3-segment by various anti-
tumor preparations is high activity of glutathion-synthase 
[26]. Thus, selective alteration of cells in S3-segment 
of mice kidney found in this study corresponds to known 
higher sensitivity of the S3-segments to damaging fac-
tors in comparison with other parts of nephron [24].
Toxic effect of PCT also touched mitochondria 
of epithelium in proximal tubules which changed their 
shape to roundish. Similar change of mitochondria 
shape was reported after injections of cisplatin, which 
has nephrotoxic effect [27]. Thereby, single applica-
tion of preparations under scheme CHOP caused 
distinct damage to epithelium of proximal tubules 
and first of all to cells of S3-segment in RLS-bearing 
mice. First injection of PCT preparations also affected 
interstitial tissue of kidneys which showed prominent 
changes: swelling of collagen fibers and break of their 
characteristic striation, increase of electron density 
of intercellular matrix (Fig. 3, c). These changes were 
present in kidney cortex during whole experiment and 
were observed in all mice treated with PCT.
Morphology of renal bodies looked unaltered in this 
period, some of the bodies showed widening of filtra-
tion space in comparison with that in non-damaged 
areas (7.26 and 2.1 μm correspondingly) what points 
to malfunction of primary urine outflow. Morphology 
of medulla and distal tubules did not visually differ from 
those in intact mice.
After second injection of PCT preparations (15th day 
post inoculation of the tumor) pathologically changed 
area of kidney cortex grew, as well as number and area 
of necroses in proximal tubules. “Sludge” of eryth-
rocytes and change of blood plasma which became 
electron dense were observed in blood vessels of kid-
neys signaling about alteration of organ blood supply. 
Morphology of other structures of kidney remained visu-
ally unchanged. Ultrastructural examination of kidneys 
showed disappearance of basal folds of plasmalemma 
in cells of proximal tubules in all mice, indicating a break 
of cell functions. Basal folds normally occupy large areas 
in proximal tubule cells providing essential square for 
water-ion transport. How can they disappear? We found 
myelin-like structures which looked similar to a ball 
of string on the cut in these cells (Fig. 3, d). We suppose 
that these structures represent final stage of basal folds 
degradation. Basal folds altered by cytostatics would 
be internalized by cells for further destruction and new 
portions of membrane components would be inserted 
into basal plasmalemma. Absence of signs of plasma-
lemma “recovery” represents another evidence of dra-
matic alteration of epithelial cells in proximal tubules 
in mice received PCT. The disappearance of basal folds 
in epithelium of proximal tubules under the PCT or single 
cytostatics influence was not reported yet.
Pathologic changes in nephrons grew a week after 
3rd injection of PCT preparations (28th day after tumor 
inoculation) and involved distal and proximal tubules 
in kidney cortex. Epithelial cells of distal tubules showed 
decreased electron density of cytoplasm and electron-
dense lipid droplets (Fig. 3, e). Epitheliocytes of proximal 
tubules contained myelin-like structures in cytoplasm 
and no basal folds. These cells significantly decreased 
in the height, number of apical microvilli markedly re-
duced, and electron-dense lipid droplets accumulated 
in cytoplasm (Fig. 3, b). Similar changes were described 
in kidneys of rats injected with doxorubicin [28, 29].
Pathological changes in kidneys increased after four 
series of injections of PCT preparations (29th day post 
inoculation of the tumor). Lesion of proximal tubules 
extended to about 50% of kidney section, necroses 
spread to considerable part of kidney cortex. Small cavi-
ties appeared in kidney interstitial tissue looking similar 
to those described in rodents after single injection 
of doxorubicin [28, 29]. It should be noted that devel-
opment of pathological changes of epithelium in distal 
tubules “falls behind” the damage of proximal tubules. 
We observed widening of filtration space and lumens 
of capillaries in renal bodies (Fig. 3, f), some capillaries 
contained clumps of electron dense plasma and cell 
detritus. Widening of capillary lumen can be a con-
sequence of malfunction of blood supply and of toxic 
impact of doxorubicin upon endothelial functions [30].
In contrast to tubular epithelium, podocytes remained 
unaltered against the background of PCT, however signs 
of activation of synthetic processes in these cells were 
observed. Increase of number of granular endoplasmic 
reticulum cisterns and length of cisterns of Golgi complex 
was seen in these cells. Number of “coated” vesicles and 
multivesicular bodies grew showing activation of clathrin-
dependent endocytosis. Similar changes in kidneys 
of mice were caused by single injection of doxorubicin 
[29]. So, podocytes possess relative resistance to impact 
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of chemotherapeutic drugs, which caused activation 
of metabolic processes in these cells.
Our study was the first attempt to visualize and 
describe changes which develop in kidneys during 
PCT treatment of lymphosarcoma. Toxic impact of PCT 
is well known [1, 2], and we tried to trace development 
of pathological changes caused by PCT in mice bear-
ing the tumor RLS. The obtained results showed that 
a b
c d
e f
Fig. 3. Outer strip area of kidney (HEx100) (a) in a mouse received PCT under scheme CHOP, 8 days after tumor RLS inoculation 
(1 series of PCT injections). Arrows show bright eosinofilic cells, asterisks show lumen of kidney tubules. Cells of proximal tubule 
(x 20000) (b), 28 days after tumor RLS inoculation, 3 series of PCT injections. 1 — nucleus, 2 — microvilli, 3 — cytoplasm, 4 — roundish 
mitochondria, arrows show electron-dense lipid droplets. Longitudinal (1) and transverse (2) sections of collagen fibers in interstitial 
tissue of mouse kidney (x100000) (c), 8 days after tumor RLS inoculation, 1 series of PCT injections. Arrows show electron-dense 
intercellular matrix. Apical area of proximal tubule cell (x80000) (d), 21 days after tumor inoculation, 2 series of PCT injections. 
1 — microvilli, arrows and box show myelin-like structures. Cells of distal tubule (x30000) (e), 21 days after tumor RLS inoculation, 
2 series of PCT injections. 1 — nucleus, 2 — cell debris in tubule’s lumen, arrows show basal folders of plasma membrane. Kidney 
glomeruli (x15000) (f), 28 days after tumor RLS inoculation, 3 series of PCT injections. 1 — widened capillary, 2 — filtration space, 
3 — mesangial tissue, 4 — nucleus of podocyte, 5 — cell debris, 6 — neutrophil. Ultrathin sections, transmission electron microscopy
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PCT leads to prominent structural damage of nephron 
cells, primarily in proximal tubules, which are respon-
sible for transport of water, ions, metabolites and xe-
nobiotics through epithelial barrier. Electron microcopy 
demonstrated that PCT impact was primarily directed 
to plasmalemma and mitochondria — the structures 
responsible for water-ion transport. Pathological 
changes found in mice obviously reflect mechanisms 
of PCT toxic impact and should be considered while 
designing of remedies for recovery of visceral organs 
after PCT of oncologic diseases.
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